Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23101 AL 23115

The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?

Chatanaka MK, Prassas I, Masters CL, Diamandis EP.

Alzheimers Dement. 2025 Jul;21(7):e70484. doi: 10.1002/alz.70484.

Targeting Inflammation in Alzheimer's Disease: Insights Into Pathophysiology and Therapeutic Avenues-A Comprehensive Review

Topalis V, Voros C, Ziaka M.

J Geriatr Psychiatry Neurol. 2026 Mar;39(2):115-144. doi: 10.1177/08919887251361578. Epub 2025 Jul 23.

Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease

Oh CK, Wang Y, Lipton SA.

Neurotherapeutics. 2025 Oct;22(6):e00707. doi: 10.1016/j.neurot.2025.e00707. Epub 2025 Jul 25.

Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease

Fu C, Li X, Liu X, Zheng Y, Ma X, Zhang B, Chen S, Hu L, Su S, Wang X, Sun J, Yin Q, Wang Y, Fu X, Bao Y, Xue Y, Xin T, Lu L, Zou G.

Transl Neurodegener. 2025 Jul 25;14(1):38. doi: 10.1186/s40035-025-00498-1.

Exploring the Endoplasmic Reticulum's Role in Alzheimer's Disease and Its Potential as a Therapeutic Target

Saleh RO, Jabir MS, Mohammed JS, Ahmad I, Ganesan S, Shankhyan A, Nanda A, Ray S, Zwamel AH, Hussein AR.

J Biochem Mol Toxicol. 2025 Aug;39(8):e70405. doi: 10.1002/jbt.70405.

The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single-Target to Multi-Target Ligands

Mehta NV, Kapadia A, Khambete M, Abhyankar A.

Chembiochem. 2025 Sep 15;26(17):e202500053. doi: 10.1002/cbic.202500053. Epub 2025 Jul 28.

Asperuloside as a promising multi-target agent for Alzheimer's disease: molecular mechanisms and therapeutic perspectives

Vashisht K, Kumar H, Ankalgi A, Ashawat MS, Rimpi, Kushawaha SK, Baldi A.

Inflammopharmacology. 2025 Aug;33(8):4311-4321. doi: 10.1007/s10787-025-01869-w. Epub 2025 Jul 28.

Intron Retention and Alzheimer's Disease (AD): A Review of Regulation Genes Implicated in AD

El-Seedy A, Ladevèze V.

Genes (Basel). 2025 Jun 30;16(7):782. doi: 10.3390/genes16070782.

The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer's Disease

Senarath RMUS, Oikari LE, Bharadwaj P, Jayasena V, Martins RN, Fernando WMADB.

Nutrients. 2025 Jul 10;17(14):2286. doi: 10.3390/nu17142286.

The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment

Miles LA, Masters CL.

J Alzheimers Dis. 2025 Sep;107(2):393-408. doi: 10.1177/13872877251361049. Epub 2025 Sep 1.

Alzheimer's Disease: Treatment Challenges for the Future

Hardy J.

J Neurochem. 2025 Aug;169(8):e70176. doi: 10.1111/jnc.70176.

The sulfation pattern of glycosaminoglycans in human brain development and neurological disorders such as Alzheimer's disease

Hirano K, Egawa H, Nishihara S.

Am J Physiol Cell Physiol. 2025 Sep 1;329(3):C801-C811. doi: 10.1152/ajpcell.00842.2024. Epub 2025 Jul 31.

Application of Traditional Chinese Medicine in Alzheimer's Disease Treatment: A Focus on the Wnt/[Formula: see text]-Catenin Pathway

Ying C, He Y, Guo Y, Fan F, Wang B, Gao J, Li Y, Zhang Y.

Am J Chin Med. 2025;53(6):1641-1683. doi: 10.1142/S0192415X25500624. Epub 2025 Aug 1.

Resveratrol's Multifaceted Potential in Alzheimer's Disease: Insights from Preclinical and Clinical Evidence

Patel S, Thornton A, Parmar MS.

Mol Neurobiol. 2025 Dec;62(12):16229-16260. doi: 10.1007/s12035-025-05234-4. Epub 2025 Aug 1.

Mushrooms: Potential Agents for the Prevention and Slowdown of Alzheimer's Disease: A Review

Galić M, Ćilerdžić J, Stajic M.

Int J Med Mushrooms. 2025;27(10):7-19. doi: 10.1615/IntJMedMushrooms.2025059428.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias